This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Vascular Dementia industry.
What is the anticipated market size of the vascular dementia industry over the next few years?
The vascular dementia market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing healthcare expenditure, rise in the number of patients diagnosed with vascular dementia, rise in healthcare professionals, growth in public health initiatives, and rise in the prevalence of diabetes.
The vascular dementia market size is expected to see rapid growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing awareness of vascular dementia, rising healthcare investments, growing aging population, rising prevalence of cardiovascular diseases, and rising prevalence of high blood pressure. Major trends in the forecast period include technological advancements, personalized care plans, telemedicine, gene therapy, and artificial intelligence.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp
What emerging drivers are expected to shape the future of the vascular dementia market?
The rising prevalence of cardiovascular disease is expected to propel the vascular dementia market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. The rising prevalence of cardiovascular diseases is driven by factors such as unhealthy lifestyles, poor dietary habits, physical inactivity, increased stress levels, aging populations, and a surge in risk factors such as obesity, diabetes, and hypertension. Cardiovascular disease increases the risk of vascular dementia by impairing blood flow to the brain, leading to cognitive decline and damage to brain cells due to reduced oxygen and nutrient supply. For instance, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the rising prevalence of cardiovascular diseases drives the vascular dementia market.
What emerging segments are shaping the future landscape of the vascular dementia industry?
The vascular dementia market covered in this report is segmented –
1) By Product: Monoclonal Antibodies, Small Molecules, Peptides
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics
Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report
What are the most notable trends influencing investment in the vascular dementia sector?
Major companies operating in the vascular dementia market are focusing on developing novel therapies, such as multimodal therapies, to sustain their position in the market. Multimodal therapies refer to the integration of various treatment approaches, such as medications, physical therapy, and psychological interventions, to treat a condition comprehensively. For instance, in January 2023, Moleac, a Singapore-based biopharmaceutical company, launched CognivAiD an evidence-based treatment specifically designed for vascular dementia (VaD), a condition with limited therapeutic options. This product combines active extracts from ginkgo, ginseng, and saffron, which have been shown to significantly slow cognitive decline in VaD patients. The unique multimodal action of CognivAiD targets key mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Supported by extensive clinical trials and a strong safety profile, CognivAiD presents a promising new treatment for individuals suffering from VaD.
How are key players in the vascular dementia market strengthening their market position?
Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam’s Group of Hospitals, Alpha Cognition Inc., Citi Health
Which geographic areas are contributing significantly to the growth of the vascular dementia sector?
North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Vascular Dementia Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998
Need Customized Data On Vascular Dementia Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
